SKL06-2026
Degenerative Changes in Injured and Adjacent Spinal Motion Segments After Conservative and Surgical Treatment of AOSpine Type A2, A3, and A4 Thoracolumbar Junction Fractures
Постоянная ссылка: https://clinomir.ru/trials/nct/NCT07672184/
Источник: ClinicalTrials.gov (U.S. National Library of Medicine). Что откуда
Простыми словами
Словарь терминов- В исследовании участвуют здоровые добровольцы.
- Исследование идёт, в реестре указано, что набор участников открыт.
- Возраст участников: 18–50 лет. Остальные условия — в блоке «Кто может участвовать».
- По плану участвуют 150 чел. во всех странах исследования.
- Центров в реестре: 1 в одном городе. Список — ниже на странице.
- Плановое окончание — 12.2027.
Пересказ собран автоматически из данных реестра, без оценки пользы и рисков. Подробно о рисках и пользе рассказывает врач центра перед подписанием согласия.
Кто может участвовать
Полный текст критериев (на английском, как в ClinicalTrials.gov) · включение: 23 · невключение: 30
Критерии включения
- Conservative Treatment Cohort:
- Age 18 to 50 years.
- Acute or subacute traumatic fracture of the thoracolumbar junction at the start of treatment.
- AOSpine type A2, A3, or A4 fracture.
- No clinical evidence of nerve root or spinal cord compression at the injured level.
- Conservative treatment of the thoracolumbar junction fracture.
- Minimum follow-up period of 1 year.
- Written informed consent for prospective follow-up or additional study procedures, when applicable.
- Surgical Treatment Cohort:
- Age 18 to 50 years.
- Acute or subacute traumatic fracture of the thoracolumbar junction at the start of treatment.
- AOSpine type A2, A3, or A4 fracture.
- No clinical evidence of nerve root or spinal cord compression at the injured level.
- Surgical treatment performed without disruption of the posterior supporting column.
- Surgical treatment may include anterior fusion, transpedicular fixation, or combined surgery without direct posterior decompression.
- Minimum follow-up period of 1 year.
- Written informed consent for prospective follow-up or additional study procedures, when applicable.
- Control Cohort:
- Age 18 to 50 years.
- At least two computed tomography examinations covering the Th9-L4 vertebral levels.
- Interval of at least 1 year between computed tomography examinations.
- Computed tomography performed for reasons unrelated to traumatic or degenerative thoracolumbar junction disease.
- No imaging artifacts at the spinal levels included in the study assessment.
Критерии невключения
- Conservative Treatment Cohort:
- Severe combined trauma.
- Severe concomitant disease.
- Systemic bone or joint disease associated with changes in facet joints or intervertebral discs, including diffuse idiopathic skeletal hyperostosis, ankylosing spondylitis, rheumatoid arthritis, or similar disorders.
- Verified osteoporosis.
- Bone density of thoracolumbar vertebrae less than 100 Hounsfield units.
- Previous spine surgery.
- American Society of Anesthesiologists physical status class 4 or 5.
- Participation in another clinical study related to treatment of spinal disease or spinal trauma.
- Withdrawal of informed consent, when applicable.
- Surgical Treatment Cohort:
- Severe combined trauma.
- Severe concomitant disease.
- Systemic bone or joint disease associated with changes in facet joints or intervertebral discs, including diffuse idiopathic skeletal hyperostosis, ankylosing spondylitis, rheumatoid arthritis, or similar disorders.
- Verified osteoporosis.
- Bone density of thoracolumbar vertebrae less than 100 Hounsfield units.
- Previous spine surgery.
- Direct posterior decompression or other surgery disrupting the posterior supporting column.
- American Society of Anesthesiologists physical status class 4 or 5.
- Participation in another clinical study related to treatment of spinal disease or spinal trauma.
- Withdrawal of informed consent, when applicable.
- Control Cohort:
- Complicated fracture of any spinal region.
- Combined trauma or severe concomitant disease limiting patient mobility.
- Systemic bone or joint disease associated with changes in facet joints or intervertebral discs, including diffuse idiopathic skeletal hyperostosis, ankylosing spondylitis, rheumatoid arthritis, or similar disorders.
- Grade 4 facet joint degeneration according to the Pathria classification at the studied levels.
- Bone density of thoracolumbar vertebrae less than 100 Hounsfield units.
- Previous spine surgery, including surgery without implants.
- Spinal fracture with injury to the posterior supporting column.
- Participation in another clinical study related to treatment of spinal disease or spinal trauma.
Источник: ClinicalTrials.gov, NCT07672184 · запись обновлена в реестре 1 июля 2026.
Дизайн и результаты
Что измеряют — первичные конечные точки (1), вторичных — 7
- Change in Facet Joint Degeneration Grade on Computed Tomography — From baseline CT to the last available follow-up CT, with a minimum interval of 1 year
Цель исследования
This observational study will evaluate how degenerative changes in the facet joints and intervertebral discs develop over time after treatment of AOSpine type A2, A3, and A4 fractures of the thoracolumbar junction. Patients treated conservatively and patients treated surgically will be compared with each other and with a control group of patients who underwent repeated computed tomography examinations for reasons unrelated to traumatic or degenerative spinal disease.
The study will assess computed tomography findings at the injured spinal motion segment and adjacent segments, including facet joint degeneration, intervertebral disc degeneration, signs of ankylosis, facet joint space parameters, and facet joint angle. Clinical outcomes in the fracture cohort will be evaluated using pain scores and validated questionnaires. The purpose of the study is to identify factors associated with progression of degenerative changes after thoracolumbar junction fractures and to clarify whether treatment method is associated with long-term degeneration of the injured and adjacent spinal motion segments.
Где проходит
1 центр в 1 городеОткуда эта информация
-
ClinicalTrials.gov (U.S. National Library of Medicine) · NCT07672184 Официальный реестр (США) · загружено 9 ноября 2026Номер протокола, название, цель, статус, набор участников, сроки, число участников, спонсор, центры
Сведения сведены и нормализованы порталом «Клиномир»: названия компаний и центров приведены к одному написанию. Нашли ошибку? Напишите нам — исправим.